BRAF and neoplasm: All of these mutations are able to hyperactivate BRAF protein causing tumor progression or inducing features of aggressiveness [31], ultimately leading to the diminished or nule expression of several thyroid-specific genes, radioiodine uptake, and pronounced hypothyroidism [32].